Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 1.736
5-Year Impact Factor – 2.135
Index Copernicus  – 168.52
MEiN – 70 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2015, vol. 24, nr 3, May-June, p. 525–530

doi: 10.17219/acem/44144

Publication type: review article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

The Role of HSP70 Heat Shock Proteins in the Pathogenesis and Treatment of Inflammatory Bowel Diseases

Paweł Samborski1,A,B,D, Marian Grzymisławski1,E,F

1 , Poznan Medical University, Poland

Abstract

Heat shock proteins (HSPs) represent an important element in the body’s defense against various damaging factors. The probably also play an important role in the pathogenesis and treatment of several diseases, including autoimmune pathology and neoplasms. Recently, several investigators have focused their attention on the involvement of the HSP70 protein family in the morbid process of inflammatory bowel diseases (IBD). The HSP70 family of is represented by two distinct forms of protein, the HSP72 protein (also known as the HSP70.1 protein), the expression of which is clearly increased in conditions of stress; and the HSP73 (or HSC73) protein, which manifests stable expression. HSP70 proteins are present in the colorectal epithelium. In patients with inflammatory bowel diseases, their expression in significantly increased during the active stage of the disease. In experimental studies, overexpression of HSP70 was found to prevent the development of inflammatory process in the large intestinal mucosa provoked by various damaging factors. In physiological conditions, various mechanisms are considered to be responsible for an increased expression of HSP70. One of them involves lymphocyte activity and the production of cytokines (mainly IL-2). Another suggested mechanism involves the presence of bacteria in the large intestine, including both physiological flora (Lactobacillus GG, Bacteroides fragilis) and pathogenic bacteria (Salmonella, Escherichia coli). HSP70 expression is probably also increased by physical activity. There is also a potential for pharmacological stimulation of HSP70 expression, linked (for example) to geranylgeranylacetone, polaprezinc and mesalazine. Thus, augmentation of HSP70 expression may become a new element in IBD therapy.

Key words

heat shock proteins, inflammatory bowel diseases.

References (41)

  1. Borges TJ, Wieten L, van Herwijnen MJ, Broere F, van der Zee R, Bonorino C, van Eden W: The anti-inflammatory mechanisms of HSP70. Front Immunol 2012, 3, 95.
  2. Ritossa FA: A new puffing pattern induced by temperature shock and DNP in Drosophila. Experientia 1962, 18, 571–573.
  3. Tissières A, Mitchell HK, Tracy U: Protein synthesis in salivary glands of Drosophila melanogaster: relation to chromosome puffs. J Mol Biol 1974, 84, 389–398.
  4. Lindquist S: The heat-shock response. Annu Rev Biochem 1986, 55, 1151–1191.
  5. Pockley AG: Heat shock proteins as regulators of the immune response. Lancet 2003, 362, 469–476.
  6. Binder RJ, Vatner R, Srivastava P: The heat-shock protein receptors: some answers and more questions. Tissue Antigens 2004, 64, 442–451.
  7. Kowalczyk DW: Therapeutic vaccines in carcinoma of the kidney (in Polish). Współczesna Onkol 2007, 11, 160–166.
  8. Mackiewicz J, Mackiewicz A: Immunotherapy of tumours and perspectives for its development (in Polish). Współczesna Onkol 2010, 14, 59–71.
  9. Cappello F, Conway de Macario E, Di Felice V, Zummo G, Macario AJ: Chlamydia trachomatis infection and anti-HSP60 immunity: the two sides of the coin. PLoS Pathog 2009, Aug, 58.
  10. Res PC, Schaar CG, Breedveld FC: Synovial fluid T cell reactivity against 65 kD heat shock protein of mycobacteria in early chronic arthritis. Lancet 1988, 2, 478–480.
  11. Salvetti M, Buttinelli C, Ristori G: T-lymphocyte reactivity to the recombinant mycobacterial 65- and 70-kDa heat shock proteins in multiple sclerosis. J Autoimmun 1992, 5, 691–702.
  12. Chodisetti SB, Rai PK, Gowthaman U: Potential T cell epitopes of Mycobacterium tuberculosis that can instigate molecular mimicry against host: implications in autoimmune pathogenesis. BMC Immunol 2012, 13, 13.
  13. Van Eden W, Thole J, van der Zee R: Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis. Nature 1988, 331, 171–173.
  14. Otaka M, Odashima M, Watanabe S: Role of heat shock proteins (molecular chaperones) in intestinal mucosal protection. Biochem Biophys Res Commun 2006, 348, 1–5.
  15. Itoh H, Tashima Y: The stress (heat shock) proteins. Int J Biochem 1991, 23, 1185–1191.
  16. Lindquist S: Varying patterns of protein synthesis in Drosophila during heat shock: implications for regulation. Dev Biol 1980, 77, 463–479.
  17. Kojima K, Musch MW, Ren H, Boone DL, Hendrickson BA, Ma A, Chang EB: Enteric flora and lymphocytederived cytokines determine expression of heat shock proteins in mouse colonic epithelial cells. Gastroenterology 2003, 124, 1395–1407.
  18. Tanaka K, Mizushima T: Protective role of HSF1 and HSP70 against gastrointestinal diseases. Int J Hyperthermia 2009, 25, 668–676.
  19. Tahara T, Shibata T, Okubo M, Ishizuka T, Kawamura T, Yamashita H, Nakamura M, Nakagawa Y, Nagasaka M, Arisawa T, Ohmiya N, Hirata I: Heat-shock protein 70–2 BB genotype is associated with reduced risks of the steroid-dependent and refractory phenotypes of ulcerative colitis. Biomed Rep 2014, 2, 555–558.
  20. Ohkawara T, Nishihira J, Ishiguro Y, Otsubo E, Nagai K, Takeda H, Kato M, Yoshiki T, Iwanaga T, Asaka M: Resistance to experimental colitis depends on cytoprotective heat shock proteins in macrophage migration inhibitory factor null mice. Immunol Lett 2006, 107, 148–154. Epub 2006, Sep 26.
  21. Ludwig D, Stahl M, Ibrahim ET, Wenzel BE, Drabicki D, Wecke A, Fellermann K, Stange EF: Enhanced intestinal expression of heat shock protein 70 in patients with inflammatory bowel diseases. Dig Dis Sci 1999, 44, 1440–1447.
  22. Tomasello G, Sciumé C, Rappa F, Rodolico V, Zerilli M, Martorana A, Cicero G, De Luca R, Damiani P, Accardo FM, Romeo M, Farina F, Bonaventura G, Modica G, Zummo G, Conway de Macario E, Macario AJ, Cappello F: HSP10, HSP70, and HSP90 immunohistochemical levels change in ulcerative colitis after therapy. Eur J Histochem 2011, 55, 38.
  23. Matsuo K, Zhang X, Ono Y, Nagatomi R: Acute stress-induced colonic tissue HSP70 expression requires commensal bacterial components and intrinsic glucocorticoid. Brain Behav Immun 2009, 23, 108–115.
  24. Otani S, Otaka M, Jin M, Okuyama A, Itoh S, Iwabuchi A, Sasahara H, Itoh H, Tashima Y, Masamune O: Effect of preinduction of heat shock proteins on acetic acid-induced colitis in rats. Dig Dis Sci 1997, 42, 833–846.
  25. Ropeleski MJ, Tang J, Walsh-Reitz MM, Musch MW, Chang EB: Interleukin-11-induced heat shock protein 25 confers intestinal epithelial-specific cytoprotection from oxidant stress. Gastroenterology 2003, 124, 1358–1368.
  26. Tanaka K, Namba T, Arai Y, Fujimoto M, Adachi H, Sobue G, Takeuchi K, Nakai A, Mizushima T: Genetic evidence for a protective role for heat shock factor 1 and heat shock protein 70 against colitis. J Biol Chem 2007, 282, 23240–23252.
  27. Tao Y, Drabik KA, Waypa TS, Musch MW, Alverdy JC, Schneewind O, Chang EB, Petrof EO: Soluble factors from Lactobacillus GG activate MAPKs and induce cytoprotective heat shock proteins in intestinal epithelial cells. Am J Physiol Cell Physiol 2006, 290, 1018–1030.
  28. Arvans DL, Vavricka SR, Ren H, Musch MW, Kang L, Rocha FG, Lucioni A, Turner JR, Alverdy J, Chang EB: Luminal bacterial flora determines physiological expression of intestinal epithelial cytoprotective heat shock proteins 25 and 72. Am J Physiol Gastrointest Liver Physiol 2005, 288, 696–704.
  29. Malago JJ, Koninkx JF, Ovelgönne HH, van Asten FJ, Swennenhuis JF, van Dijk JE: Expression levels of heat shock proteins in enterocyte-like Caco-2 cells after exposure to Salmonella enteritidis. Cell Stress Chaperones 2003, 8, 194–203.
  30. Deitch E, Beck S, Cruz N, De Maio A: Induction of heat shock gene expression in colonic epithelial cells after incubation with Escherichia coli or endotoxin. Crit Care Med 1995, 23, 1371–1376.
  31. Chen Y, Noble EG: Is exercise beneficial to the inflammatory bowel diseases? An implication of heat shock proteins. Med Hypotheses 2009, 72, 84–86.
  32. Melling CW, Thorp DB, Noble EG: Regulation of myocardial heat shock protein 70 gene expression following exercise. J Mol Cell Cardiol 2004, 37, 847–855.
  33. Noble EG, Ho R, Dzialoszynski T: Exercise is the primary factor associated with HSP70 induction in muscle of treadmill running rats. Acta Physiol (Oxf) 2006, 187, 495–501.
  34. Paroo Z, Haist JV, Karmazyn M, Noble EG: Exercise improves postischemic cardiac function in males but not females: consequences of a novel sex-specific heat shock protein 70 response. Circ Res 2002, 90, 911–917.
  35. Ohkawara T, Nishihira J, Takeda H, Katsurada T, Kato K, Yoshiki T, Sugiyama T, Asaka M: Protective effect of geranylgeranylacetone on trinitrobenzene sulfonic acid-induced colitis in mice. Int J Mol Med 2006, 17, 229–234.
  36. Ohkawara T, Takeda H, Nishiwaki M, Nishihira J, Asaka M: Protective effects of heat shock protein 70 induced by geranylgeranylacetone on oxidative injury in rat intestinal epithelial cells. Scand J Gastroenterol 2006, 41, 312–317.
  37. Ohkawara T, Takeda H, Kato K, Miyashita K, Kato M, Iwanaga T, Asaka M: Polaprezinc (N-(3-aminopropionyl)- L-histidinato zinc) ameliorates dextran sulfate sodium-induced colitis in mice. Scand J Gastroenterol 2005, 40, 1321–1327.
  38. Ohkawara T, Nishihira J, Nagashima R, Takeda H, Asaka M: Polaprezinc protects human colon cells from oxidative injury induced by hydrogen peroxide: relevant to cytoprotective heat shock proteins. World J Gastroenterol 2006, 12, 6178–6181.
  39. Qin Y, Naito Y, Handa O: Heat shock protein 70-dependent protective effect of polaprezinc on acetylsalicylic acid-induced apoptosis of rat intestinal epithelial cells. J Clin Biochem Nutr 2011, 49, 174–181. DOI: 10.3164/ /jcbn.11–26. Epub 2011 Jun 17.
  40. Burress GC, Musch MW, Jurivich DA: Effects of mesalamine on the HSP72 stress response in rat IEC-18 intestinal epithelial cells. Gastroenterology 1997, 113, 1474–1479.
  41. Xue H, Sufit A, Wischmeyer P: Glutamine Therapy Improves Outcome of In Vitro and In Vivo Experimental Colitis Models JPEN J Parenter Enteral Nutr 2011, 35, 188–197.